RNA-Seq: Principles, Methods, Computational Analysis

Published on : January 26, 2023January 26, 2023 Published by : Chris Frew

This 5-Day workshop combines a unique mix of hands-on wet bench and electronic laboratory experiences together with a series of lectures spanning an introduction to the concepts of RNA sequencing [….]

Single Cell RNA-Seq

Published on : January 26, 2023January 26, 2023 Published by : Chris Frew

This in-depth lecture and hands-on laboratory workshop (wet lab & in silica) is ideal for those research and bench scientists who are interested in a comprehensive introduction to single cell [….]

RNA Therapeutics & Delivery US 2023

Published on : January 25, 2023January 25, 2023 Published by : Chris Frew

Across four in-depth sessions the latest improvements pushing the industry forward will be addressed: from stability & clinical manufacturing, RNA computational design approaches, through to case studies & recent developments in [….]

Python for Research Scientists

Published on : January 13, 2023January 25, 2023 Published by : BioBuzz Media

Python is a popular scripting language that is used by data professionals because of its many-popular statistical libraries. The live remote three-day lecture and hands-on computer-based laboratory workshop is designed [….]

Multiplex Immunofluorescence in Immune Oncology, Workshop & Symposium

Published on : January 13, 2023January 25, 2023 Published by : BioBuzz Media

This four day program is divided into a two-day symposium with lectures presented by world class scientists in the field of immuno-oncology and with representation by all the main multiplex [….]

Flow Cytometry: Principles, Methods and Applications

Published on : January 13, 2023January 25, 2023 Published by : BioBuzz Media

This four day program is ideal for those who are looking for an in-depth, hands-on introduction to Flow Cytometry. Developed and taught by active researchers, this workshop will focus on [….]

miRecule Inc. closes $5.7 M to Create Breakthrough RNA Therapies for Cancer and Muscular Dystrophy

Published on : May 27, 2021May 27, 2021 Published by : BioBuzz Media

miRecule, Inc. (“miRecule”), an emerging biotech company focused on the development of cutting-edge RNA therapeutics, announced today it has closed over $5.7M in seed funding. The funding round was led by Alexandria Venture Investments, along with Boutique Venture Partners, Pathway Bioventures, Alumni Ventures Group, and national angel investors, with additional funding coming from the Maryland Momentum Fund and the FSHD Society. This funding includes a non-dilutive $2M Phase II SBIR grant from the National Cancer Institute.

NIH spinout raises millions to attack drug-resistant cancers with RNA. It has big plans.

Published on : May 24, 2021May 24, 2021 Published by : BioBuzz Media

Gaithersburg’s miRecule Inc. has raised $5.7 million in fresh funding, CEO Anthony Saleh told us Monday, positioning the company to start human testing for its lead candidate to treat head and neck cancer.

Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer

Published on : February 22, 2021February 22, 2021 Published by : BioBuzz Media

Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer Descartes-11 specifically designed to integrate into standard treatment regimen for newly diagnosed multiple myeloma without [….]